Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.87
-0.17 (-1.00%)
At close: Feb 21, 2025, 4:00 PM
16.94
+0.07 (0.41%)
After-hours: Feb 21, 2025, 6:35 PM EST
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.28 billion as of February 21, 2025. Its market cap has increased by 209.06% in one year.
Market Cap
1.28B
Enterprise Value
698.93M
1-Year Change
209.06%
Ranking
Category
Stock Price
$16.87
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.28B, an increase of 81.82%. That is a compound annual growth rate of 13.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.28B | -4.07% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |